HUBERMAN: There are other steroid hormones as well, of course
It is also associated with cardiovascular benefits due to its lipid-lowering and anti-inflammatory effects
It is naturally released during collagen damage
Coverage varies among insurers
India GLP-1 Receptor Agonist Market Trends The GLP-1 receptor agonist market in India, though relatively small at the moment, has strong growth potential due to the second-largest diabetes population in the world (77 million cases), a fast-growing obesity rate (a current 40 million adults), and increasing access to healthcare
In descending order, the medications used included serotonin-norepinephrine reuptake inhibitors (used by 182 patients), gabapentin (155 patients), tricyclic antidepressants (134 patients), trazodone (59 patients), pregabalin (46 patients), muscle relaxants (45 patients), montelukast (26 patients), -blockers (21 patients), aripiprazole (12 patients), histamine 1 or histamine 2 blockers (11 patients), naltrexone (8 patients), amphetamine- or methylphenidate-based stimulants (8 patients), midodrine (7 patients), fludrocortisone (6 patients), non-amphetamine stimulants (4 patients), pyridostigmine (4 patients), -blockers (1 patient), and droxidopa (1 patient)